Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02937350 · ClinicalTrials.gov registry record · Phase 1
Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT02937350 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 88 participants.
The verdict
NCT02937350, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
The goal of this study is to better understand vitamin D catabolism and how it is affected by CKD and race.
Interventions
- DRUG D6-25-hydroxyvitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2021-01-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02937350
The ClinicalTrials.gov registry entry for NCT02937350 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D6-25-hydroxyvitamin D3 is the first listed.
NCT02937350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02937350 about?
NCT02937350 is a clinical study titled "Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease". The goal of this study is to better understand vitamin D catabolism and how it is affected by CKD and race.
What is the current status of trial NCT02937350?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2017-03-01. Estimated completion is 2021-01-01.
What interventions are being tested in trial NCT02937350?
The interventions under investigation include: D6-25-hydroxyvitamin D3 (DRUG).
Who is sponsoring clinical trial NCT02937350?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.